Reconsidering milrinone: Time to revive the oral form for drug repurposing?

نویسندگان
doi
10.18502/cjn.v24i3.21605
چکیده

کلیدواژه‌ها
Fatemeh Afra1, Elahe Shaban2, Amirmahdi Mojtahedzadeh3, Mojtaba Mojtahedzadeh4, Milrinone, Phosphodiesterase 3 Inhibitors, Neuroprotective Agents, Subarachnoid Hemorrhage